<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Lymphoma is the most common hematopoietic tumor in dogs. The standard diagnostic approach and staging includes detailed clinical history, physical examination and extended laboratory workup including lymph node cytology. Multidrug chemotherapy is the main treatment of the disease. Often, owners are concerned about the side effects of the treatment and the quality of life of their dog during chemotherapy. The aim of this study was to analyze the health related wellbeing of the patients with lymphoma previous, during and at the end of the chemotherapy. Five patients with multicentric lymphoma were monitored in three phases (beginning, middle and end of chemotherapy). The monitoring included clinical examination, laboratory analyses and a questionnaire for the owner. Results revealed significant improvement (p&lt; 0.1) of the basic red blood cells parameters (RBC, PCV and Hb), platelets (PLT) as well as liver enzymes (ALT, AST) and protein status (total protein and globulin). Regarding the life quality assessed by the owners, dogs' appetite, general health compared to each visit and the current quality of life were significantly improved (p&lt;0.1) and all of the owners were satisfied with the decision for chemotherapy.</p>
</abstract>

Lymphoma is the most common hematopoietic tumor in dogs. The standard diagnostic approach and staging includes detailed clinical history, physical examination and extended laboratory workup including lymph node cytology. Multidrug chemotherapy is the main treatment of the disease. Often, owners are concerned about the side effects of the treatment and the quality of life of their dog during chemotherapy. The aim of this study was to analyze the health related wellbeing of the patients with lymphoma previous, during and at the end of the chemotherapy. Five patients with multicentric lymphoma were monitored in three phases (beginning, middle and end of chemotherapy). The monitoring included clinical examination, laboratory analyses and a questionnaire for the owner. Results revealed significant improvement (p< 0.1) of the basic red blood cells parameters (RBC, PCV and Hb), platelets (PLT) as well as liver enzymes (ALT, AST) and protein status (total protein and globulin). Regarding the life quality assessed by the owners, dogs' appetite, general health compared to each visit and the current quality of life were significantly improved (p<0.1) and all of the owners were satisfied with the decision for chemotherapy.

Evaluation of Health Related Quality of Life in Dogs Treated with Chemotherapy for Lymphoma

University Ss. Cyril and Methodius - Skopje

Faculty of Veterinary Medicine St. “Lazar Pop-Trajkov”

Acta Veterinaria

This work is licensed under the Creative Commons Attribution 4.0 International License.

Lymphoma is the most common hematopoietic tumor in dogs. The standard diagnostic approach and staging includes detailed clinical history, physical examination...

Evaluation of Health Related Quality of Life in Dogs Treated with Chemotherapy for Lymphoma

Article Category: Research article

Online veröffentlicht: 01. Juli 2023

Seitenbereich: 218 - 230

DOI: https://doi.org/10.2478/acve-2023-0017

Schlüsselwörter
Canine lymphoma, chemotherapy, quality of life, questionnaire

© 2023 Elena Atanaskova Petrov et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Evaluation of Health Related Quality of Life in Dogs Treated with Chemotherapy for Lymphoma

Article Category: Research article

Online veröffentlicht: 01. Juli 2023

Seitenbereich: 218 - 230

DOI: https://doi.org/10.2478/acve-2023-0017

SchlüsselwörterCanine lymphoma, chemotherapy, quality of life, questionnaire

© 2023 Elena Atanaskova Petrov et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Schlüsselwörter
Canine lymphoma, chemotherapy, quality of life, questionnaire